In the rapidly moving field, questions remain regarding long-term safety, durability of remission, and the FDA’s approach to ...
The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally ...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced new clinical data presented at the 2026 Tandem ...
New retrospective analysis showed Orca-T with reduced intensity conditioning (RIC) demonstrated favorable OS, RFS and GRFS compared to PTCyCompany announced first patients dosed in the Phase 2 ...
The 74 reports that U.S. eighth graders' science skills and interest have declined post-COVID, with proficiency falling from 33% to 29%.
Administering immunochemotherapy before 3 pm vs later significantly improved survival in patients with treatment-naïve stage IIIC-IV NSCLC.
Senior Lucas Menendez works in a top cardiovascular research lab on campus and started the “Healthy Hearts” student club, ...
Blocked from reporting on U.S. Education Linda McMahon's visit to a Colts Neck school, the Asbury Park Press filed open ...
Make America Healthy Again" Movement Spotlights Shared Health Crisis Between Humans and Pets — New Analysis Reveals How ...
The plan, the first in over 10 years, follows uneven enrollment changes across the district’s seven elementary schools.
HighRes Biosolutions and Opentrons Labworks are launching a partnership to develop an AI agent-to-agent laboratory automation ...
ACCESS trial results at the 2026 Tandem Meetings reinforce mismatched unrelated donors as safe, effective and well-tolerated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results